AbbVie ABBV Earnings Call Transcripts

NYSE ABBV
$283.54 -2.47 (-0.86%)
At close: Nov 19, 2026 · 4:02 PM EST
27 earnings calls on file for AbbVie, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

AbbVie Q3 2026 Earnings Call

Oct 30, 2026 10,231 words · 44 min read
  • Elizabeth SheaSenior Vice President, Investor Relations
  • Robert MichaelChairman and Chief Executive Officer
  • Jeffrey StewartExecutive Vice President, Chief Commercial Officer
  • Roopal ThakkarExecutive Vice President, Research and Development, Chief Scientific Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

AbbVie Earnings Call Transcripts

Calls27
LatestOct 30, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 27 AbbVie transcripts Register to get access to AbbVie’s earnings call transcripts.

AbbVie Earnings Call Transcripts API

Pull AbbVie's earnings call transcripts - the full call, prepared remarks and the Q&A, speaker by speaker - into your own models and apps with the Business Quant Transcripts API. Add fyq (e.g. Q2 2025) for a given call. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/transcripts?ticker=ABBV&api_key=YOUR_API_KEY